Cargando…
Localisation of renin-angiotensin system (RAS) components in breast
Angiotensin II has mitogenic and angiogenic effects and its receptors are widespread, particularly in epithelial tissue. Tissue renin angiotensin systems (tRASs) may be a local source of angiotensin II that has specific paracrine functions. To investigate the presence of a tRAS in normal human breas...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360491/ https://www.ncbi.nlm.nih.gov/pubmed/16755291 http://dx.doi.org/10.1038/sj.bjc.6603213 |
_version_ | 1782153062376275968 |
---|---|
author | Tahmasebi, M Barker, S Puddefoot, J R Vinson, G P |
author_facet | Tahmasebi, M Barker, S Puddefoot, J R Vinson, G P |
author_sort | Tahmasebi, M |
collection | PubMed |
description | Angiotensin II has mitogenic and angiogenic effects and its receptors are widespread, particularly in epithelial tissue. Tissue renin angiotensin systems (tRASs) may be a local source of angiotensin II that has specific paracrine functions. To investigate the presence of a tRAS in normal human breast and tumours. Immunocytochemistry, and quantitative RT–PCR was used to establish: (i) the presence and localisation of RAS components, (ii) the possibility of their involvement in cancer. (1) mRNA coding for angiotensinogen, prorenin, angiotensin converting enzyme (ACE), and both AT1 and AT2 receptors was demonstrated in normal and diseased breast tissues. (2) (pro)renin was identified in epithelial cells in both normal and diseased tissue, but in invasive carcinoma, its distribution was mostly confined to fibroblasts or could not be detected at all. (3) Angiotensin converting enzyme was shown in epithelial cells in both normal and malignant tissue. The results are consistent with the hypothesis that a tRAS is present in the breast, and is disrupted in invasive cancer. |
format | Text |
id | pubmed-2360491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23604912009-09-10 Localisation of renin-angiotensin system (RAS) components in breast Tahmasebi, M Barker, S Puddefoot, J R Vinson, G P Br J Cancer Molecular Diagnostics Angiotensin II has mitogenic and angiogenic effects and its receptors are widespread, particularly in epithelial tissue. Tissue renin angiotensin systems (tRASs) may be a local source of angiotensin II that has specific paracrine functions. To investigate the presence of a tRAS in normal human breast and tumours. Immunocytochemistry, and quantitative RT–PCR was used to establish: (i) the presence and localisation of RAS components, (ii) the possibility of their involvement in cancer. (1) mRNA coding for angiotensinogen, prorenin, angiotensin converting enzyme (ACE), and both AT1 and AT2 receptors was demonstrated in normal and diseased breast tissues. (2) (pro)renin was identified in epithelial cells in both normal and diseased tissue, but in invasive carcinoma, its distribution was mostly confined to fibroblasts or could not be detected at all. (3) Angiotensin converting enzyme was shown in epithelial cells in both normal and malignant tissue. The results are consistent with the hypothesis that a tRAS is present in the breast, and is disrupted in invasive cancer. Nature Publishing Group 2006-07-03 2006-06-06 /pmc/articles/PMC2360491/ /pubmed/16755291 http://dx.doi.org/10.1038/sj.bjc.6603213 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Molecular Diagnostics Tahmasebi, M Barker, S Puddefoot, J R Vinson, G P Localisation of renin-angiotensin system (RAS) components in breast |
title | Localisation of renin-angiotensin system (RAS) components in breast |
title_full | Localisation of renin-angiotensin system (RAS) components in breast |
title_fullStr | Localisation of renin-angiotensin system (RAS) components in breast |
title_full_unstemmed | Localisation of renin-angiotensin system (RAS) components in breast |
title_short | Localisation of renin-angiotensin system (RAS) components in breast |
title_sort | localisation of renin-angiotensin system (ras) components in breast |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360491/ https://www.ncbi.nlm.nih.gov/pubmed/16755291 http://dx.doi.org/10.1038/sj.bjc.6603213 |
work_keys_str_mv | AT tahmasebim localisationofreninangiotensinsystemrascomponentsinbreast AT barkers localisationofreninangiotensinsystemrascomponentsinbreast AT puddefootjr localisationofreninangiotensinsystemrascomponentsinbreast AT vinsongp localisationofreninangiotensinsystemrascomponentsinbreast |